Inventor · disambiguated record
Stephen F. Carroll
Also filed as: CARROLL STEPHEN · CARROLL STEPHEN F · CARROLL STEPHEN FITZHUGH
31 granted patents·13 pending applications·777 citations·filing 1985–2022
97Inventor score
Top patents by PatentIndex Score
44 records- 0196US4709017AModified toxic vaccinesHARVARD COLLEGE·Filed 1985·Granted Nov 24, 1987·206 cites·2 claims
- 0293US10604559B2Multi-valent hepatitis B virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2016·Granted Mar 31, 2020·15 cites·18 claims
- 0391US6376217B1Fusion proteins and polynucleotides encoding gelonin sequencesXOMA TECHNOLOGY LTD·Filed 2000·Granted Apr 23, 2002·18 cites·15 claims
- 0491US5744580AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted Apr 28, 1998·57 cites·36 claims
- 0590US11535664B2Multi-valent hepatitis B virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2020·Granted Dec 27, 2022·2 cites·19 claims
- 0690US5093475AHindered linking agents derived from 2-iminothiolanes and methodsXOMA CORP·Filed 1989·Granted Mar 3, 1992·30 cites·48 claims
- 0786US6093573AThree-dimensional structure of bactericidal/permeability-increasing protein (BPI)XOMA·Filed 1997·Granted Jul 25, 2000·82 cites·6 claims
- 0886US5621083AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted Apr 15, 1997·44 cites·10 claims
- 0985US6649742B1Immunotoxins comprising ribosome-inactivating proteinsXOMA TECHNOLOGY LTD·Filed 2000·Granted Nov 18, 2003·37 cites·20 claims
- 1085US5484705AMethod for quantifying lipopolysaccharide binding proteinXOMA CORP·Filed 1994·Granted Jan 16, 1996·50 cites·2 claims
- 1184US6146631AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1997·Granted Nov 14, 2000·30 cites·54 claims
- 1284US5837491APolynucleotides encoding gelonin sequencesXOMA CORP·Filed 1994·Granted Nov 17, 1998·55 cites·20 claims
- 1382US6599880B1Bactericidal/permeability-increasing protein (BPI) deletion analogsXOMA CORP·Filed 2000·Granted Jul 29, 2003·5 cites·39 claims
- 1479US10822399B2IgA multi-specific binding moleculesIGM BIOSCIENCES INC·Filed 2015·Granted Nov 3, 2020·2 cites·17 claims
- 1578US7153932B2Immunotoxins comprising ribosome-inactivating proteinsRES DEV FOUNDATION·Filed 2003·Granted Dec 26, 2006·4 cites·11 claims
- 1677US5756699AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted May 26, 1998·18 cites·53 claims
- 1771US5466580AMethod for quantifying BPI in body fluidsXOMA CORP·Filed 1993·Granted Nov 14, 1995·28 cites·3 claims
- 1869US2022403009A1Multimeric coronavirus binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1967US5804367AMethod for quantifying LBP in body fluidsXOMA CORP·Filed 1995·Granted Sep 8, 1998·30 cites·11 claims
- 2065US5466581AMethod for quantifying BPI in body fluidsXOMA CORP·Filed 1993·Granted Nov 14, 1995·23 cites·3 claims
- 2164US7081334B2Method for quantifying LBP in body fluidsXOMA CORP·Filed 2001·Granted Jul 25, 2006·4 cites·17 claims
- 2264US6146850AProteins encoding gelonin sequencesXOMA CORP·Filed 1998·Granted Nov 14, 2000·10 cites·4 claims
- 2364US2023058162A1Multimeric coronavirus binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2459US2003166196A1Fusion proteins and polynucleotides encoding gelonin sequencesXOMA TECHNOLOGY LTD·Filed 2002·Application pending·0 cites
- 2559US2005209837A1Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling or related proteinsBEAMER LESA J·Filed 2004·Application pending·0 cites
- 2657US2004002452A1Therapeutic uses of N-terminal BPI protein products in ANCA-positive patientsXOMA TECHNOLOGY LTD·Filed 2002·Application pending·0 cites
- 2756US2022267415A1Multimeric sars-cov-2 binding molecules and uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2856US2003236187A9Uses of lipopolysaccharide binding proteinXOMA CORP·Filed 2001·Application pending·0 cites
- 2955US2005130889A1Bacterical/permability-increasing protein(BPI) deletion analogsFiled 2003·Application pending·0 cites
- 3053US5183904AHindered linking agents and methodsXOMA CORP·Filed 1991·Granted Feb 2, 1993·4 cites·6 claims
- 3152US2011150907A1Methods and materials for gastrointestinal delivery of pathogen/toxin binding agentsFARALLONE HOLDINGS BV·Filed 2009·Application pending·0 cites
- 3252US2015183908A1Compositions comprising crosslinked cation-binding polymers and uses thereofRELYPSA INC·Filed 2013·Application pending·0 cites
- 3351US2004014153A1Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of related proteinsFiled 2002·Application pending·0 cites
- 3449US6087126ABactericidal/permeability-increasing protein (BPI) deletion analogsXOMA CORP·Filed 1999·Granted Jul 11, 2000·5 cites·10 claims
- 3546US6013631ABactericidal/permeability-increasing protein (BPI) deletion analogsXOMA CORP·Filed 1998·Granted Jan 11, 2000·6 cites·7 claims
- 3645US2003194377A1Therapeutic uses of BPI protein products in cystic fibrosis patientsFiled 2000·Application pending·0 cites
- 3744US2015196585A1Compositions comprising crosslinked cation-binding polymers and uses thereofRELYPSA INC·Filed 2013·Application pending·0 cites
- 3838US5891618AMethod for quantifying LBP in body fluidsXOMA CORP·Filed 1997·Granted Apr 6, 1999·5 cites·11 claims
- 3935US5990082AUses of lipopolysaccharide binding proteinXOMA CORP·Filed 1997·Granted Nov 23, 1999·2 cites·3 claims
- 4034US5821064AMethod of screening for an active inflammatory state by determining the concentration of extracellular BPIXOMA CORP·Filed 1994·Granted Oct 13, 1998·4 cites·6 claims
- 4132US6482796B2Therapeutic uses of N-terminal BPI protein products in ANCA-positive patientsXOMA CORP·Filed 1999·Granted Nov 19, 2002·0 cites·17 claims
- 4231US6759203B1Method for quantifying BPI in body fluidsXOMA CORP·Filed 1998·Granted Jul 6, 2004·1 cites·7 claims
- 4330US6306824B1Uses of lipopolysaccharide binding proteinXOMA CORP·Filed 1999·Granted Oct 23, 2001·0 cites·12 claims
- 4429US6274328B1Method for quantifying LBP in body fluidsXOMA CORP·Filed 1998·Granted Aug 14, 2001·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →